Remy Luthringer
CIK 1610384 · View on SEC EDGAR ↗
First SEC filing: June 5, 2026 · Latest: June 5, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | NERV | S | 3,641 | $3.76 | $13,690 | 68,994 Direct | -5.01% | Disposed | 26.7% (price as of 2026-08-20) |
| May 1, 2023 | NERV | S | 23,753 | $3.85 | $91,449 | 72,635 Direct | -24.64% | Disposed | 23.8% (price as of 2026-08-20) |
| Dec. 16, 2020 | NERV | S | 1,300 | $2.64 | $3,432 | 66,490 Direct | -1.92% | Disposed | -77.4% (price as of 2026-08-20) |
| Dec. 17, 2019 | NERV | S | 2,412 | $7.10 | $17,125 | 49,040 Direct | -4.69% | Disposed | -91.6% (price as of 2026-08-20) |
| Dec. 17, 2018 | NERV | S | 2,604 | $7.46 | $19,426 | 32,702 Direct | -7.38% | Disposed | -92.0% (price as of 2026-08-20) |
| Dec. 14, 2017 | NERV | S | 2,194 | $5.85 | $12,835 | 16,556 Direct | -11.70% | Disposed | -89.8% (price as of 2026-08-20) |
| Feb. 6, 2017 | NERV | S 10b5-1 | 2,185 | $11.00 | $24,035 | 0 Direct | -100.00% | Disposed | -94.6% (price as of 2026-08-20) |
| Feb. 3, 2017 | NERV | S 10b5-1 | 32,096 | $11.02 | $353,698 | 0 Direct | -100.00% | Disposed | -94.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 4, 2023 | NERV | Employee Stock Option (right to buy) | Common Stock (100,450) | $6.41 | Oct. 3, 2033 | 100,450 | Acquired |
| Dec. 13, 2022 | NERV | Employee Stock Option (right to buy) | Common Stock (45,000) | $3.11 | Dec. 12, 2032 | 45,000 | Acquired |
| Feb. 16, 2022 | NERV | Employee Stock Option (right to buy) | Common Stock (505,000) | $0.79 | Feb. 15, 2032 | 505,000 | Acquired |
| Dec. 14, 2020 | NERV | Restricted Stock Unit | Common Stock (18,750) | — | — | 18,750 | Disposed |
| Oct. 13, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock (200,000) | $3.50 | Oct. 12, 2030 | 200,000 | Acquired |
| June 19, 2020 | NERV | Employee Stock Option (right to buy) | Common Stock (354,302) | $7.11 | Dec. 31, 2029 | 354,302 | Acquired |
| Dec. 31, 2019 | NERV | Employee Stock Option (right to buy) | Common Stock (95,698) | $7.11 | Dec. 30, 2029 | 95,698 | Acquired |
| Dec. 14, 2019 | NERV | Restricted Stock Unit | Common Stock (18,750) | — | — | 18,750 | Disposed |
| Dec. 14, 2018 | NERV | Restricted Stock Unit | Common Stock (18,750) | — | — | 18,750 | Disposed |
| Dec. 11, 2018 | NERV | Employee Stock Option (right to buy) | Common Stock (410,000) | $7.96 | Dec. 10, 2028 | 410,000 | Acquired |
| Jan. 2, 2018 | NERV | Employee Stock Option (Right to Buy) | Common Stock (200,000) | $6.20 | Jan. 2, 2028 | 200,000 | Acquired |
| Dec. 14, 2017 | NERV | Restricted Stock Unit | Common Stock (18,750) | — | — | 18,750 | Disposed |
| Dec. 13, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock (350,000) | $6.10 | Dec. 13, 2027 | 350,000 | Acquired |
| Feb. 6, 2017 | NERV | Stock Option (Right to Buy) | Common Stock (2,185) | $4.71 | Dec. 3, 2025 | 2,185 | Disposed |
| Feb. 3, 2017 | NERV | Stock Option (Right to Buy) | Common Stock (32,096) | $4.71 | Dec. 3, 2025 | 32,096 | Disposed |
| Dec. 14, 2016 | NERV | Stock Option (Right to Buy) | Common Stock (150,000) | — | Dec. 13, 2026 | 150,000 | Acquired |
| Dec. 14, 2016 | NERV | Restricted Stock Unit | Common Stock (75,000) | — | — | 75,000 | Acquired |
| Dec. 4, 2015 | NERV | Stock Option (right to buy) | Common Stock (320,000) | — | Dec. 3, 2025 | 320,000 | Acquired |
| April 14, 2015 | NERV | Stock Option (right to buy) | Common Stock (399,623) | — | April 13, 2025 | 399,623 | Acquired |
| June 30, 2014 | NERV | Employee Stock Option (Right to Buy) | Common Stock (207,869) | $6.00 | June 29, 2024 | 207,869 | Acquired |
| June 30, 2014 | NERV | Employee Stock Option (Right to Buy) | Common Stock (441,973) | $6.00 | June 29, 2024 | 441,973 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 30, 2014 | NERV | Common Stock | 926,604 | Indirect |